Good guy or bad guy: The opposing roles of microRNA 125b in cancer

Cell Communication and Signaling

Volumn 12, Issue 1, 2014, Pages

  Banzhaf Strathmann, Julia ^a   Edbauer, Dieter ^a,b,c  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Germany 3 Munich Cluster for Systems Neurology   (Germany)

Author keywords

Cancer; MicroRNA; miR 125b; Oncogene; Tumor suppressor gene

Indexed keywords

MESSENGER RNA; MICRORNA 125B; MICRORNA; MIRN125 MICRORNA, HUMAN;

BLADDER CANCER; BRAIN TUMOR; BREAST CANCER; CARCINOGENESIS; COLON CANCER; DOWN REGULATION; ENDOMETRIUM CANCER; EWING SARCOMA; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HEAD AND NECK TUMOR; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SKIN CANCER; TUMOR SUPPRESSOR GENE; UPREGULATION; GENETICS; METABOLISM; NEOPLASM;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84899902278     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-12-30     Document Type: Review

References (84)

1. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Lee RC, Feinbaum RL, Ambros V, Cell 1993 75 843 854 10.1016/0092-8674(93)90529-Y 8252621 (Pubitemid 24014542)
2. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Zhao Y, Samal E, Srivastava D, Nature 2005 436 214 220 10.1038/nature03817 15951802 (Pubitemid 41021266)
3. MicroRNA-directed cleavage of HOXB8 mRNA. Yekta S, Shih IH, Bartel DP, Science 2004 304 594 596 10.1126/science.1097434 15105502 (Pubitemid 38541919)
4. A pancreatic islet-specific microRNA regulates insulin secretion. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M, Nature 2004 432 226 230 10.1038/nature03076 15538371 (Pubitemid 39545853)
5. MicroRNAs and neurodegeneration: role and impact. Abe M, Bonini N, Trends Cell Biol 2013 23 30 36 10.1016/j.tcb.2012.08.013 23026030
6. Clustering and conservation patterns of human microRNAs. Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T, Margalit H, Nucleic Acids Res 2005 33 2697 2706 10.1093/nar/gki567 15891114 (Pubitemid 41511287)
7. MicroRNAs: small RNAs with a big role in gene regulation. He L, Hannon GJ, Nat Rev Genet 2004 5 522 531 10.1038/nrg1379 15211354 (Pubitemid 38868508)
8. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Ebert MS, Neilson JR, Sharp PA, Nat Meth 2007 4 721 726 10.1038/nmeth1079 (Pubitemid 47338166)
9. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Haraguchi T, Ozaki Y, Iba H, Nucleic Acids Res 2009 37 43 10.1093/nar/gkp040 19223327
10. Silencing of microRNAs in vivo with 'antagomirs'. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M, Nature 2005 438 685 689 10.1038/nature04303 16258535 (Pubitemid 41740580)
11. MicroRNAs in Cancer. Garzon R, Calin GA, Croce CM, Annu Rev Med 2009 60 167 179 10.1146/annurev.med.59.053006.104707 19630570
12. miRCancer: a microRNA-cancer association database constructed by text mining on literature. Xie B, Ding Q, Han H, Wu D, Bioinformatics 2013 29 638 644 10.1093/bioinformatics/btt014 23325619
13. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Wightman B, Ha I, Ruvkun G, Cell 1993 75 855 862 10.1016/0092-8674(93)90530-4 8252622 (Pubitemid 24014543)
14. Uncovering new functions for microRNAs in Caenorhabditis elegans. Abbott AL, Curr Biol 2011 21 668 R671 10.1016/j.cub.2011.07.027 21920301
15. The lin-4 microRNA: The ultimate micromanager. Esquela-Kerscher A, Cell Cycle 2014 13 1060 1061 24584060
16. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM, Proc Natl Acad Sci U S A 2004 101 2999 3004 10.1073/pnas.0307323101 14973191 (Pubitemid 38327724)
17. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T, Volinia S, Croce CM, Oncogene 2013 33 702 712 23416980
18. Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. Smits M, Wurdinger T, van het Hof B, Drexhage JA, Geerts D, Wesseling P, Noske DP, Vandertop WP, de Vries HE, Reijerkerk A, FASEB J 2012 26 2639 2647 10.1096/fj.11-202820 22415301
19. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Kappelmann M, Kuphal S, Meister G, Vardimon L, Bosserhoff AK, Oncogene 2013 32 2984 2991 10.1038/onc.2012.307 22797068
20. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Shang C, Lu YM, Meng LR, Med Sci Monit 2012 18 R149 BR155 22460089
21. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Henson BJ, Bhattacharjee S, O'Dee DM, Feingold E, Gollin SM, Genes Chromosomes Cancer 2009 48 569 582 10.1002/gcc.20666 19396866
22. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. Liu LH, Li H, Li JP, Zhong H, Zhang HC, Chen J, Xiao T, Biochem Biophys Res Commun 2011 416 31 38 10.1016/j.bbrc.2011.10.117 22093834
23. Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation. He J, Xu Q, Jing Y, Agani F, Qian X, Carpenter R, Li Q, Wang XR, Peiper SS, Lu Z, Liu LZ, Jiang BH, EMBO Rep 2012 13 1116 1122 10.1038/embor.2012.162 23146892
24. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, Liao DZ, Huang MY, Hou JH, Wu QL, Zeng MS, Huang WL, Zeng YX, Shao JY, Cancer Res 2011 71 3552 3562 10.1158/0008-5472.CAN-10-2435 21444677
25. MicroRNA miR-125b causes leukemia. Bousquet M, Harris M, Zhou B, Lodish H, Proc Natl Acad Sci 2010 107 21558 21563 10.1073/pnas.1016611107 21118985
26. miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells. Willimott S, Wagner SD, J Biol Chem 2012 287 2608 2617 10.1074/jbc.M111.285718 22139839
27. miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies. Lin KY, Zhang XJ, Feng DD, Zhang H, Zeng CW, Han BW, Zhou AD, Qu LH, Xu L, Chen YQ, J Biol Chem 2011 286 38253 38263 10.1074/jbc.M111.269670 21903586
28. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, Sun L, Ji G, Shi Y, Han Z, Han S, Nie Y, Chen X, Zhao Q, Ding J, Wu K, Daiming F, Mol Cancer Res 2011 9 824 833 10.1158/1541-7786.MCR-10-0529 21628394
29. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT, Duh QY, Clark OH, Kebebew E, Cancer 2012 118 3426 3432 10.1002/cncr.26587 22006248
30. MIcrorna expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM, JAMA 2007 297 1901 1908 10.1001/jama.297.17.1901 17473300 (Pubitemid 46707844)
31. MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Xia HF, He TZ, Liu CM, Cui Y, Song PP, Jin XH, Ma X, Cell Physiol Biochem 2009 23 347 358 10.1159/000218181 19471102
32. MicroRNA-125b is a novel negative regulator of p53. Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V, Lodish HF, Lim B, Genes Dev 2009 23 862 876 10.1101/gad.1767609 19293287
33. MicroRNA signatures in human cancers. Calin GA, Croce CM, Nat Rev Cancer 2006 6 857 866 10.1038/nrc1997 17060945 (Pubitemid 44629897)
34. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t (2;11) (p21; q23) translocation. Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C, Lippert E, Talmant P, Lafage-Pochitaloff M, Leroux D, Gervais C, Viguié F, Lai JL, Terre C, Beverlo B, Sambani C, Hagemeijer A, Marynen P, Delsol G, Dastugue N, Mecucci C, Brousset P, J Exp Med 2008 205 2499 2506 10.1084/jem.20080285 18936236
35. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Sonoki T, Iwanaga E, Mitsuya H, Asou N, Leukemia 2005 19 2009 2010 10.1038/sj.leu.2403938 16151463 (Pubitemid 41554016)
36. Depletion of Human Micro-RNA miR-125b Reveals That It Is Critical for the Proliferation of Differentiated Cells but Not for the Down-regulation of Putative Targets during Differentiation. Lee YS, Kim HK, Chung S, Kim K-S, Dutta A, J Biol Chem 2005 280 16635 16641 10.1074/jbc.M412247200 15722555 (Pubitemid 41389120)
37. Conserved Regulation of p53 Network Dosage by MicroRNA-125b Occurs through Evolving miRNA-Target Gene Pairs. Le MT, Shyh-Chang N, Khaw SL, Chin L, Teh C, Tay J, O'Day E, Korzh V, Yang H, Lal A, Lieberman J, Lodish HF, Lim B, PLoS Genet 2011 7 1002242 10.1371/journal.pgen.1002242 21935352
38. MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Nishida N, Yokobori T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Kuwano H, Mori M, Int J Oncol 2011 38 1437 1443 21399871
39. Control of apoptosis by p53. Fridman JS, Lowe SW, Oncogene 2003 22 9030 9040 10.1038/sj.onc.1207116 14663481 (Pubitemid 38121703)
40. Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b. Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, Benz CC, J Biol Chem 2007 282 1479 1486 10.1074/jbc.M609383200 17110380 (Pubitemid 47076526)
41. Biology of HER2 and its importance in breast cancer. Yarden Y, Oncology 2001 61 Suppl 2 1 13 (Pubitemid 33033419)
42. Molecular mechanisms of erbB2-mediated breast cancer chemoresistance. Tan M, Yu D, Adv Exp Med Biol 2007 608 119 129 10.1007/978-0-387-74039-3-9 17993237
43. Emu/miR-125b transgenic mice develop lethal B-cell malignancies. Enomoto Y, Kitaura J, Hatakeyama K, Watanuki J, Akasaka T, Kato N, Shimanuki M, Nishimura K, Takahashi M, Taniwaki M, Haferlach C, Siebert R, Dyer MJ, Asou N, Aburatani H, Nakakuma H, Kitamura T, Sonoki T, Leukemia 2011 25 1849 1856 10.1038/leu.2011.166 21738213
44. Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. Yuxia M, Zhennan T, Wei Z, J Cancer Res Clin Oncol 2012 138 2045 2050 10.1007/s00432-012-1285-0 22806310
45. A new recurrent translocation t (11;14) (q24; q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Chapiro E, Russell LJ, Struski S, Cave H, Radford-Weiss I, Valle VD, Lachenaud J, Brousset P, Bernard OA, Harrison CJ, Nguyen-Khac F, Leukemia 2010 24 1362 1364 10.1038/leu.2010.93 20485370
46. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D, Proc Natl Acad Sci U S A 2010 107 14235 14240 10.1073/pnas.1009798107 20660734
47. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO, Nat Cell Biol 2007 9 654 659 10.1038/ncb1596 17486113 (Pubitemid 47214727)
48. Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy.Li H-J, Hua F, Wang B, Mao W, Feng X-R, Li J-Y, Wang X, Acta Pharmacol Sin 2013 34 309 313 10.1038/aps.2012.125 22983388
49. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo Z, Dong W, Huang J, Lin T, Int J Cancer 2011 128 1758 1769 10.1002/ijc.25509 20549700
50. microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer. Wu D, Ding J, Wang L, Pan H, Zhou Z, Zhou J, Qu P, Oncol Lett 2013 5 829 834 23425975
51. MicroRNA-143 as a Tumor Suppressor for Bladder Cancer. Lin T, Dong W, Huang J, Pan Q, Fan X, Zhang C, Huang L, J Urol 2009 181 1372 1380 10.1016/j.juro.2008.10.149 19157460
52. miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression. Ferracin M, Bassi C, Pedriali M, Pagotto S, D'Abundo L, Zagatti B, Corrà F, Musa G, Callegari E, Lupini L, Volpato S, Querzoli P, Negrini M, Mol Cancer 2013 12 130 10.1186/1476-4598-12-130 24165569
53. miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-alpha, CCNJ, and MEGF9. Feliciano A, Castellvi J, Artero-Castro A, Leal JA, Romagosa C, Hernández-Losa J, Peg V, Fabra A, Vidal F, Kondoh H, Ramón Y Cajal S, Lleonart ME, PLoS One 2013 8 76247 10.1371/journal.pone.0076247 24098452
54. MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR. Rajabi H, Jin C, Ahmad R, McClary C, Joshi MD, Kufe D, Genes Cancer 2010 1 62 68 10.1177/1947601909357933 20729973
55. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs. McKinsey EL, Parrish JK, Irwin AE, Niemeyer BF, Kern HB, Birks DK, Jedlicka P, Oncogene 2011 30 4910 4920 10.1038/onc.2011.197 21643012
56. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway. Li J, You T, Jing J, Cell Prolif 2014 47 152 160 10.1111/cpr.12093 24517182
57. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Gong J, Zhang JP, Li B, Zeng C, You K, Chen MX, Yuan Y, Zhuang SM, Oncogene 2013 32 3071 3079 10.1038/onc.2012.318 22824797
58. MicroRNA-125b Functions as a Tumor Suppressor in Hepatocellular Carcinoma Cells. Jia HY, Wang YX, Yan WT, Li HY, Tian YZ, Wang SM, Zhao HL, Int J Mol Sci 2012 13 8762 8774 10.3390/ijms13078762 22942733
59. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression. Zhao A, Zeng Q, Xie X, Zhou J, Yue W, Li Y, Pei X, J Genet Genomics 2012 39 29 35 10.1016/j.jgg.2011.12.003 22293115
60. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, Stokes A, Francis T, Hughart N, Hubble L, Zhuang SM, Meng F, J Hepatol 2011 55 1339 1345 10.1016/j.jhep.2011.04.015 21703189
61. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Liang L, Wong CM, Ying Q, Fan DN, Huang S, Ding J, Yao J, Yan M, Li J, Yao M, Ng IO, He X, Hepatology 2010 52 1731 1740 10.1002/hep.23904 20827722
62. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Li W, Xie L, He X, Li J, Tu K, Wei L, Wu J, Guo Y, Ma X, Zhang P, Pan Z, Hu X, Zhao Y, Xie H, Jiang G, Chen T, Wang J, Zheng S, Cheng J, Wan D, Yang S, Li Y, Gu J, Int J Cancer 2008 123 1616 1622 10.1002/ijc.23693 18649363
63. MiR-125b targets BCL3 and suppresses ovarian cancer proliferation. Guan Y, Yao H, Zheng Z, Qiu G, Sun K, Int J Cancer 2011 128 2274 2283 10.1002/ijc.25575 20658525
64. Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis. He J, Jing Y, Li W, Qian X, Xu Q, Li F-S, Liu L-Z, Jiang B-H, Jiang Y, PLoS One 2013 8 56647 10.1371/journal.pone.0056647 23437196
65. miR-125b inhibits Connexin43 and promotes glioma growth. Jin Z, Xu S, Yu H, Yang B, Zhao H, Zhao G, Cell Mol Neurobiol 2013 33 1143 1148 10.1007/s10571-013-9980-1 24046143
66. MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation. Shi L, Zhang J, Pan T, Zhou J, Gong W, Liu N, Fu Z, You Y, Brain Res 2010 1312 120 126 19948152
67. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ, DeVere White RW, Proc Natl Acad Sci U S A 2007 104 19983 19988 10.1073/pnas.0706641104 18056640
68. Oncomir miR-125b suppresses p14 (ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. Amir S, Ma AH, Shi XB, Xue L, Kung HJ, Devere White RW, PLoS One 2013 8 61064 10.1371/journal.pone.0061064 23585871
69. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells. Sun D, Layer R, Mueller AC, Cichewicz MA, Negishi M, Paschal BM, Dutta A, Oncogene 2013 33 1448 1457 23503464
70. Widespread deregulation of microRNA expression in human prostate cancer. Ozen M, Creighton CJ, Ozdemir M, Ittmann M, Oncogene 2008 27 1788 1793 10.1038/sj.onc.1210809 17891175 (Pubitemid 351380263)
71. MicroRNA-125b Promotes Neuronal Differentiation in Human Cells by Repressing Multiple Targets. Le MTN, Xie H, Zhou B, Chia PH, Rizk P, Um M, Udolph G, Yang H, Lim B, Lodish HF, Mol Cell Biol 2009 29 5290 5305 10.1128/MCB.01694-08 19635812
72. Opposing roles of connexin43 in glioma progression. Sin WC, Crespin S, Mesnil M, Biochim Biophys Acta 2012 1818 2058 2067 10.1016/j.bbamem.2011.10.022 22063721
73. Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. Sen A, Prizant H, Light A, Biswas A, Hayes E, Lee HJ, Barad D, Gleicher N, Hammes SR, Proc Natl Acad Sci U S A 2014 111 308 313 10.1073/pnas.1312213111 24368852
74. Hallmarks of Cancer: The Next Generation. Hanahan D, Weinberg Robert A, Cell 2011 144 646 674 10.1016/j.cell.2011.02.013 21376230
75. The p53 pathway in breast cancer. Gasco M, Shami S, Crook T, Breast Cancer Res 2002 4 70 76 11879567 (Pubitemid 34248123)
76. p53 mutations in human cancers. Hollstein M, Sidransky D, Vogelstein B, Harris CC, Science 1991 253 49 53 10.1126/science.1905840 1905840 (Pubitemid 21917115)
77. MicroRNA control of signal transduction. Inui M, Martello G, Piccolo S, Nat Rev Mol Cell Biol 2010 11 252 263 20216554
78. Epigenetic gene silencing in cancer: the DNA hypermethylome. Esteller M, Hum Mol Genet 2007 16 50 R59 10.1093/hmg/ddm018 17613547 (Pubitemid 47241842)
79. The TRIM-NHL Protein TRIM32 Activates MicroRNAs and Prevents Self-Renewal in Mouse Neural Progenitors. Schwamborn JC, Berezikov E, Knoblich JA, Cell 2009 136 913 925 10.1016/j.cell.2008.12.024 19269368
80. The hallmarks of cancer. Hanahan D, Weinberg RA, Cell 2000 100 57 70 10.1016/S0092-8674(00)81683-9 10647931 (Pubitemid 30046295)
81. Chromosomal translocations in cancer. Nambiar M, Kari V, Raghavan SC, Biochim Biophys Acta 2008 1786 139 152 18718509
82. Androgen receptor signaling in prostate cancer development and progression. Tindall D, Lonergan P, J Carcinog 2011 10 20 10.4103/1477-3163. 83937 21886458
83. Mouse xenograft models vs GEM models for human cancer therapeutics. Richmond A, Su Y, Dis Model Mech 2008 1 78 82 10.1242/dmm.000976 19048064
84. MicroRNA therapeutics. Broderick JA, Zamore PD, Gene Ther 2011 18 1104 1110 10.1038/gt.2011.50 21525952